In contrast to all findings that revealed that YAP expression correlates with a more aggressive breast cancer and with a poor survival and disease free rates, a recent study by Cao et al. demonstrated that YAP expression is associated with the low grade type of breast cancer luminal A. In addition, the study revealed that YAP expression correlates with favorable DFS and overall survival in patients with luminal A breast cancer and with favorable DFS association among patients with invasive ductal carcinoma, luminal B (HER2-), and luminal B (HER2+) breast cancers (45). Here, ERBB2 is linked to breast carcinoma.